Chemoinformaics analysis of 2-Methyl-2-(4-methyl-3-cyclohexen-1-yl)oxirane
| Molecular Weight | 152.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 9 |
| Exact Molecular Weight | 152.12 | nRing | 2 |
| Solubility: LogS | -3.408 | nHRing | 1 |
| Solubility: LogP | 3.489 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 0 | BPOL | 17.7873 |
| QED | 0.415 |
| Synth | 3.713 |
| Natural Product Likeliness | 3.075 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.404 |
| MDCK | 0.0000243 |
| BBB | 0.362 |
| PPB | 0.928724 |
| VDSS | 1.829 |
| FU | 0.0566557 |
| CYP1A2-inh | 0.518 |
| CYP1A2-sub | 0.33 |
| CYP2c19-inh | 0.208 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.069 |
| CYP2c9-sub | 0.384 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.468 |
| CYP3a4-inh | 0.069 |
| CYP3a4-sub | 0.264 |
| CL | 16.569 |
| T12 | 0.308 |
| hERG | 0.014 |
| Ames | 0.02 |
| ROA | 0.021 |
| SkinSen | 0.787 |
| Carcinogencity | 0.865 |
| EI | 0.952 |
| Respiratory | 0.07 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.945709 |